Restructuring charges (3) 52 - (52) -
Total costs and expenses 164,535 (5,162) (10,020) 149,353
Operating loss (23,828) 5,162 11,057 (7,609)
Interest income, net (547) - - (547)
Other income, net 579 - - 579
Provision for income taxes (6) (284) - - (284)
Net income (loss) $(24,080) $5,162 $11,057 $(7,861)
Net income (loss) per share -
basic and diluted $(0.51) $(0.17)
Shares used in computing net loss
per share - basic and diluted 47,301 47,301
Year Ended
December 31, 2006
Stock-
based Other Adjusted
Reported Comp Adjustments (1)
Revenues:
Product revenue (4) $69,248 $- $273 $69,521
Service revenue 24,454 - - 24,454
License fees and contract
revenue (4) 14,169 - 1,603 15,772
Total revenues 107,871 - 1,876 109,747
Cost and Expenses:
Cost of product revenue (2),(4) 45,459 (506) 9 44,962
Cost of service revenue (2) 14,917 (151) - 14,766
Cost of license revenue (4) 219 - 149 368
Research and development (2),(5) 24,591 (975) (2,898) 20,718
Selling, general and
administrative
'/>"/>
| SOURCE Caliper Life Sciences, Inc. Copyright©2008 PR Newswire. All rights reserved |